Atlas Trials

Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects

Clinical trial NCT01657552 · COMPLETED

Trial details

NCT number
NCT01657552
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Thrombocytopaenia
Start date
2012-08-01
Primary completion
2012-10-26
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.